Skip to content

Comparing the efficacy of Virechan and Uttarabasti in infertility due to endometrial factor.

Add on efficacy of virechan along with uttarabasti in the management of endometrial factor of infertility: an open label randomized comparative clinical trial - NIL

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/064324
Enrollment
136
Registered
2024-03-18
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N972- Female infertility of uterine origin

Interventions

None listed

Sponsors

All india institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Females having active marital life of minimum 1 year. Females of child bearing age from 20 to 40 years. Females with primary or secondary type of infertility with endometrial thickness less than 10 mm diagnosed by TVS will be selected. Females suitable for Virechana and Uttarabasti procedures.

Exclusion criteria

Exclusion criteria: Females having age less than 20 years and more than 40 years. Any active pelvic infection, sexually transmitted disease, tuberculosis ,congenital deformities of genital tract,carcinoma of genital tract,endometriosis,uterine polyp or any debilitating diseases will be excluded from the study. Females not suitable for Virechana and Uttarabasti.

Design outcomes

Primary

MeasureTime frame
Improvement in Appelbaum USSR score as per USG .Timepoint: Day 0 3rd month

Secondary

MeasureTime frame
Hysteroscopic appearance of good mid secretary endometrium. Timepoint: day 0, after 3 months

Countries

India

Contacts

Public ContactDr VIJILA V

All india institute of Ayurveda ,Delhi

kd44ayu@yahoo.co.in8920900968

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026